SSTR1 (somatostatin receptor 1)

2003-02-01  

Identity

HGNC
LOCATION
14q21.1
LOCUSID
ALIAS
SRIF-2,SS-1-R,SS1-R,SS1R

Other Information

Locus ID:

NCBI: 6751
MIM: 182451
HGNC: 11330
Ensembl: ENSG00000139874

Variants:

dbSNP: 6751
ClinVar: 6751
TCGA: ENSG00000139874
COSMIC: SSTR1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000139874ENST00000267377P30872

Expression (GTEx)

0
5
10
15

Pathways

PathwaySourceExternal ID
Neuroactive ligand-receptor interactionKEGGko04080
Neuroactive ligand-receptor interactionKEGGhsa04080
cAMP signaling pathwayKEGGhsa04024
cAMP signaling pathwayKEGGko04024
Signal TransductionREACTOMER-HSA-162582
Signaling by GPCRREACTOMER-HSA-372790
GPCR ligand bindingREACTOMER-HSA-500792
Class A/1 (Rhodopsin-like receptors)REACTOMER-HSA-373076
Peptide ligand-binding receptorsREACTOMER-HSA-375276
GPCR downstream signalingREACTOMER-HSA-388396
G alpha (i) signalling eventsREACTOMER-HSA-418594

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
334912862021Predictive and prognostic significance of tumour subtype, SSTR1-5 and e-cadherin expression in a well-defined cohort of patients with acromegaly.6
336758662021The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors.3
350143322021Selectivity Comparison of Tumor-Imaging Probes Designed Based on Various Tumor-Targeting Strategies: A Proof of Concept Study.1
334912862021Predictive and prognostic significance of tumour subtype, SSTR1-5 and e-cadherin expression in a well-defined cohort of patients with acromegaly.6
336758662021The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors.3
350143322021Selectivity Comparison of Tumor-Imaging Probes Designed Based on Various Tumor-Targeting Strategies: A Proof of Concept Study.1
292820352017Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets.21
292820352017Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets.21
264744342016Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors.12
264744342016Prognostic Value of Somatostatin Receptor Subtypes in Pancreatic Neuroendocrine Tumors.12
257349192015Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.17
259624062015An immunohistochemical investigation of the expression of somatostatin receptor subtypes - should therapeutic trials be performed to determine the efficacy of somatostatin analogs in treating advanced thyroid malignances?4
257349192015Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.17
259624062015An immunohistochemical investigation of the expression of somatostatin receptor subtypes - should therapeutic trials be performed to determine the efficacy of somatostatin analogs in treating advanced thyroid malignances?4
245124862014Does somatostatin have a role in the regulation of cortisol secretion in primary pigmented nodular adrenocortical disease (ppnad)? a clinical and in vitro investigation.3

Citation

Dessen P

SSTR1 (somatostatin receptor 1)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/42401